{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Azilsartan+Medoxomil", "query": { "intervention": "Placebo for Azilsartan Medoxomil" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 16, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Azilsartan+Medoxomil&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T06:10:38.783Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01774591", "title": "Effect of Azilsartan on Aldosterone in Postmenopausal Females", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan medoximil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "45 Years to 70 Years · Female only" }, "enrollment_count": 21, "start_date": "2013-01", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2017-11-09", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01774591" }, { "nct_id": "NCT00762736", "title": "Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Pioglitazone and azilsartan", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 704, "start_date": "2004-07", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2012-02-28", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Sierra Vista, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Sierra Vista", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00762736" }, { "nct_id": "NCT00591266", "title": "Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan Medoxomil and amlodipine", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 566, "start_date": "2007-10", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2011-07-22", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 50, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Anaheim, California + 47 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00591266" }, { "nct_id": "NCT01033071", "title": "Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Essential Hypertension" ], "interventions": [ { "name": "Azilsartan medoxomil and chlorthalidone", "type": "DRUG" }, { "name": "Olmesartan medoxomil and hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1071, "start_date": "2010-01", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2012-02-07", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 84, "location_summary": "Gulf Shores, Alabama • Litchfield Park, Arizona • Mesa, Arizona + 81 more", "locations": [ { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01033071" }, { "nct_id": "NCT00846365", "title": "Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Essential Hypertension" ], "interventions": [ { "name": "Azilsartan medoxomil and chlorthalidone", "type": "DRUG" }, { "name": "Olmesartan medoxomil-hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1085, "start_date": "2009-03", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2012-03-13", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 70, "location_summary": "Birmingham, Alabama • Haleyville, Alabama • Hueytown, Alabama + 67 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Haleyville", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Tallassee", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00846365" }, { "nct_id": "NCT00818883", "title": "Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Essential Hypertension" ], "interventions": [ { "name": "Azilsartan medoxomil and chlorthalidone", "type": "DRUG" }, { "name": "Azilsartan medoxomil and hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 609, "start_date": "2009-02", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2012-02-07", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Gulf Shores, Alabama • Scottsboro, Alabama + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Sierra Vista", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00818883" }, { "nct_id": "NCT01496430", "title": "Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension", "Diabetes" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Azilsartan medoxomil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2012-01", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2015-05-06", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 68, "location_summary": "Birmingham, Alabama • Green Valley, Arizona • Tempe, Arizona + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Green Valley", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Buena Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01496430" }, { "nct_id": "NCT00696436", "title": "An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan medoxomil", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" }, { "name": "Olmesartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1291, "start_date": "2008-04", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2011-04-19", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 86, "location_summary": "Alabaster, Alabama • Ozark, Alabama • Green Valley, Arizona + 83 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Ozark", "state": "Alabama" }, { "city": "Green Valley", "state": "Arizona" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00696436" }, { "nct_id": "NCT00591773", "title": "Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan medoxomil and chlorthalidone", "type": "DRUG" }, { "name": "Chlorthalidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 551, "start_date": "2007-09", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2011-04-19", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 46, "location_summary": "Huntsville, Alabama • Montgomery, Alabama • Buena Park, California + 43 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Buena Park", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00591773" }, { "nct_id": "NCT00376181", "title": "Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Pioglitazone and Azilsartan", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2006-06", "completion_date": "2007-05", "has_results": false, "last_update_posted_date": "2010-06-22", "last_synced_at": "2026-10-02T06:10:38.783Z", "location_count": 59, "location_summary": "Huntsville, Alabama • Tallassee, Alabama • Little Rock, Arkansas + 56 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Tallassee", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Auburn", "state": "California" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00376181" } ] }